{"version":"1.0","type":"link","title":"Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial.","author_name":"Han F 외","author_url":"https://prs-insight.online/author/Han%20F","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167016","thumbnail_width":1200,"thumbnail_height":630}